Actinium Pharmaceuticals
NY - New YorkPharmaceutical
Focus: Actinium Pharmaceuticals is a specialized biotech company focused on targeted radiotherapy for hematologic malignancies, headquartered in New York. The company operates at clinical-stage maturity with a focused pipeline primarily in acute myeloid leukemia.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Open Jobs
1
Should You Work at Actinium Pharmaceuticals?
AI assessmentBest suited for specialists in radiotherapy or AML who value deep focus over scale; verify financial stability before committing.
Why Work Here
- Emerging expertise in targeted radiotherapy (Ac-225, I-131 isotopes), a differentiated modality with less competition than traditional small molecules or standard mAbs
- Multiple Phase 2/3 programs in acute myeloid leukemia offer near-term visibility into clinical readouts and potential regulatory catalysts
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195
LeukemiaClinical Trials (1)
NCT00672165Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
Phase 1Help build intelligence for Actinium Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.